Bringing together families affected by neuroblastoma from across the globe with those who work to treat, help, and support them.
Hosted online over two days, this FREE virtual event provided valuable content for families, neuroblastoma survivors, clinicians and other healthcare professionals, researchers and charitable organisations.
The event programme included live and pre-recorded sessions, presentations from internationally renowned experts, specialised conversation rooms and parent-driven Q&A. Live sessions were recorded and are available for on-demand viewing through the link above. Sessions topics included:
Information for newly diagnosed families
Overview of international clinical trial landscape
Drug development and emerging research
Supportive care management
Solving Kids’ Cancer UK is a parent-led charity, our vision is a future where no child dies of neuroblastoma or suffers due to its treatment. We provide emotional and practical support to families and our research focus is on clinical trials, seeking to explore new ways of treating neuroblastoma, providing hope and options for children and their families now and in the future. www.solvingkidscancer.org.uk
Solving Kids' Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208646).
The Children’s Neuroblastoma Cancer Foundation (CNCF) is the premier source for neuroblastoma information and resources. Comprised of families just like yours, we are committed to finding a cure for neuroblastoma through research, education, awareness and advocacy. Visit www.cncfhope.org/ to find out more about the work of CNCF.
Children's Neuroblastoma Cancer Foundation (CNCF) is recognized as a public charity under Section
501(c)(3) of the US Internal Revenue Code.
Federal ID 36-4370725.
Solving Kids’ Cancer is not just our name, it’s our mission. We focus on aggressive childhood cancers with low survival rates—because Every Kid Deserves to Grow Up. Solving Kids' Cancer (SKC) helps accelerate clinical trials of next-generation treatments with an understanding of the global childhood cancer research landscape